Discount Agreement for Hydroxycarbamide (FTA) with DAK-Gesundheit
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydroxycarbamid (ausschl. Dafo. FTA), ATC L01XX05 f. d. Z. 01.08.2026 - 31.07.2028 (zzgl. V.-Option 1x12 Mon)
Status
Active
Submission Deadline
974 days remaining
Contracting authority
Location
Hamburg, Germany
Estimated Value
€1
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
bkms-ef-3d7a3406-d658-4045-9e5b-02882fb5f15e
Source
DAK-Gesundheit is entering into non-exclusive discount agreements for Hydroxycarbamide (FTA) to ensure supply until August 1, 2028. This allows all interested pharmaceutical companies to join under attractive conditions.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- SomeTenderDocID1NON-RESTRICTED-DOCUMENT
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
Legal Basis
32014L0024